Nomura Holdings Inc. Lowers Stock Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Nomura Holdings Inc. significantly reduced its stake in Sabra Healthcare REIT by 78.5%, selling 44,739 shares and now holding only 12,287 shares valued at approximately $215,000.
• Multiple analysts have raised their price targets for Sabra Healthcare REIT, with a consensus average price target now at $20.71, indicating a positive market outlook for the stock.
• Sabra Healthcare REIT's latest earnings report exceeded expectations, posting a $0.38 earnings per share and a revenue increase of 7.4% from the previous year, along with a 6.3% dividend yield.

Nomura Holdings Inc. lessened its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 78.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,287 shares of the real estate investment trust's stock after selling 44,739 shares during the quarter. Nomura Holdings Inc.'s holdings in Sabra Healthcare REIT were worth $215,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the company. SVB Wealth LLC bought a new position in shares of Sabra Healthcare REIT during the 1st quarter valued at approximately $34,000. UMB Bank n.a. raised its stake in Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after purchasing an additional 1,621 shares in the last quarter. Wealth Preservation Advisors LLC bought a new position in Sabra Healthcare REIT during the first quarter valued at $38,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Sabra Healthcare REIT by 61.2% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock worth $49,000 after buying an additional 1,065 shares in the last quarter. Finally, Assetmark Inc. increased its holdings in shares of Sabra Healthcare REIT by 37.8% in the 1st quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after buying an additional 989 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Trading Up 1.1%

SBRA stock traded up $0.20 during mid-day trading on Thursday, reaching $19.13. The company had a trading volume of 1,657,545 shares, compared to its average volume of 2,279,879. The company has a market capitalization of $4.59 billion, a PE ratio of 25.17, a price-to-earnings-growth ratio of 1.51 and a beta of 0.88. The firm has a 50 day moving average of $18.68 and a 200 day moving average of $17.95. Sabra Healthcare REIT, Inc. has a 12 month low of $15.60 and a 12 month high of $20.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. During the same quarter in the previous year, the firm posted $0.36 earnings per share. The company's revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 157.89%.

Analyst Ratings Changes

A number of research analysts recently commented on SBRA shares. JMP Securities increased their price target on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. Truist Financial raised their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a research note on Tuesday, September 2nd. Scotiabank lifted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. Wells Fargo & Company increased their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Finally, BMO Capital Markets raised their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research report on Monday, August 25th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of "Moderate Buy" and an average target price of $20.71.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.